Contrast-Enhanced Mammography and Radiomics Analysis for Noninvasive Breast Cancer Characterization: Initial Results

[1]  S. Aime,et al.  CEST‐MRI for glioma pH quantification in mouse model: Validation by immunohistochemistry , 2018, NMR in biomedicine.

[2]  Maciej A Mazurowski,et al.  Breast cancer MRI radiomics: An overview of algorithmic features and impact of inter‐reader variability in annotating tumors , 2018, Medical physics.

[3]  Teresa Wu,et al.  Classification of Breast Masses Using a Computer-Aided Diagnosis Scheme of Contrast Enhanced Digital Mammograms , 2018, Annals of Biomedical Engineering.

[4]  H. Hricak,et al.  Background, current role, and potential applications of radiogenomics , 2018, Journal of magnetic resonance imaging : JMRI.

[5]  Michael R. Harowicz,et al.  A study of association of Oncotype DX recurrence score with DCE-MRI characteristics using multivariate machine learning models , 2018, Journal of Cancer Research and Clinical Oncology.

[6]  N. Houssami,et al.  Rapid review: radiomics and breast cancer , 2018, Breast Cancer Research and Treatment.

[7]  Theodoros N. Arvanitis,et al.  Radiomics in paediatric neuro‐oncology: A multicentre study on MRI texture analysis , 2018, NMR in biomedicine.

[8]  Teresa Wu,et al.  Computer-aided diagnosis of contrast-enhanced spectral mammography: A feasibility study. , 2018, European journal of radiology.

[9]  Qianjin Feng,et al.  Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI , 2018, European Radiology.

[10]  Janice S. Sung,et al.  Comparison of screening CEDM and MRI for women at increased risk for breast cancer: A pilot study. , 2017, European journal of radiology.

[11]  Philippe Lambin,et al.  Quantitative radiomics studies for tissue characterization: a review of technology and methodological procedures , 2017, The British journal of radiology.

[12]  Honglin Wan,et al.  Differentiating brain metastases from different pathological types of lung cancers using texture analysis of T1 postcontrast MR , 2016, Magnetic resonance in medicine.

[13]  Lars J. Grimm,et al.  Breast MRI radiogenomics: Current status and research implications , 2016, Journal of magnetic resonance imaging : JMRI.

[14]  Erich P Huang,et al.  MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays. , 2016, Radiology.

[15]  S Gommers,et al.  Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study , 2016, European Radiology.

[16]  Paul Kinahan,et al.  Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.

[17]  Joseph O. Deasy,et al.  Breast cancer subtype intertumor heterogeneity: MRI‐based features predict results of a genomic assay , 2015, Journal of magnetic resonance imaging : JMRI.

[18]  Eric M Blaschke,et al.  MRI phenotype of breast cancer: Kinetic assessment for molecular subtypes , 2015, Journal of magnetic resonance imaging : JMRI.

[19]  Jinzhong Yang,et al.  IBEX: an open infrastructure software platform to facilitate collaborative work in radiomics. , 2015, Medical physics.

[20]  G. Newstead,et al.  Intratumoral heterogeneity of the distribution of kinetic parameters in breast cancer: comparison based on the molecular subtypes of invasive breast cancer , 2015, Breast Cancer.

[21]  Maciej A Mazurowski,et al.  Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging. , 2014, Radiology.

[22]  Maxine Jochelson.  Contrast-enhanced digital mammography. , 2014, Radiologic clinics of North America.

[23]  Joachim E. Wildberger,et al.  Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme , 2014, European Radiology.

[24]  S. Nemec,et al.  Texture‐based and diffusion‐weighted discrimination of parotid gland lesions on MR images at 3.0 Tesla , 2013, NMR in biomedicine.

[25]  Janice S Sung,et al.  Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. , 2013, Radiology.

[26]  M. Krohn,et al.  Contrast-enhanced spectral mammography versus MRI: Initial results in the detection of breast cancer and assessment of tumour size , 2013, European Radiology.

[27]  T. Sørlie,et al.  Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement. , 2012 .

[28]  S Michiels,et al.  Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  Maryellen Giger,et al.  Computerized three-class classification of MRI-based prognostic markers for breast cancer , 2011, Physics in medicine and biology.

[30]  Serge Muller,et al.  Dual-energy contrast-enhanced digital mammography: initial clinical results , 2011, European Radiology.

[31]  Siegfried Trattnig,et al.  Texture‐based classification of focal liver lesions on MRI at 3.0 Tesla: A feasibility study in cysts and hemangiomas , 2010, Journal of magnetic resonance imaging : JMRI.

[32]  M. Dowsett,et al.  American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Journal of oncology practice.

[33]  M. Giger,et al.  Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers. , 2010, Radiology.

[34]  Michal Strzelecki,et al.  MaZda - A software package for image texture analysis , 2009, Comput. Methods Programs Biomed..

[35]  Felix Diekmann,et al.  Tomosynthesis and contrast-enhanced digital mammography: recent advances in digital mammography , 2007, European Radiology.